Apellis Announces Closing of Previously Announced Exchanges of Approximately $201.1 Million in Principal Amount of Its 3.500% Convertible Senior Notes Due 2026 for Common Stock

NEXT STORY
Subperiosteal Dental Implants Market 2021-2028 | Size, Share, Growth, Trends, Competitive Landscape, Revenue, Analysis, Forecast Report
PREV STORY
2021 Outlook on Decentralized Clinical Trials – Cloud-based Platform to Achieve Scalability and Workflow Standardization Presents Opportunities
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immutep Achieves Fast Track Designation From US FDA For Efti, A Soluble Lag-3 Protein, In First Line Recurrent/Metastatic Head & Neck Cancer

author_avatar
NASDAQ Market News

TMS Program Hosts Open House to Introduce Deep Transcranial Magnetic Stimulation (Deep TMS) Helmet to Treat Major Depressive Disorder (MDD) and Obsessive-Compulsive Disorder (OCD)

author_avatar
NASDAQ Market News

Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets

author_avatar
NASDAQ Market News